Cargando…
Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
Autores principales: | Zhang, Quan, Ye, Zhan, Bignotti, Antonia, Zheng, X. Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665299/ http://dx.doi.org/10.1182/blood-2022-163715 |
Ejemplares similares
-
Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19
por: Zhang, Quan, et al.
Publicado: (2023) -
Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection
por: Zhang, Quan, et al.
Publicado: (2023) -
Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19
por: Zhang, Quan, et al.
Publicado: (2022) -
Arginine vasopressin increases plasma levels of von Willebrand factor in sheep
por: Rehberg, S, et al.
Publicado: (2009) -
Plasma fibrinolysis is related to the SOFA score but not to the von Willebrand factor on ICU admission
por: Boudjeltia, K Zouaoui, et al.
Publicado: (2008)